(1)
Shabeeb, Z. A.; Faraj, Y. F.; Mtashar, B. A.; Hussein, M. S.; Hasan, A. F. Immune-Biomarker Signature Predicts Early Molecular Response in Iraqi Chronic Myeloid Leukemia Patients Receiving Front-Line Tyrosine-Kinase Inhibitors. Regul. Mech. Biosyst. 2025, 16, e25197.